Furthermore, PD-L2 expression was not associated with CRC risk and poor patient survival outcomes (Fig. 2C, D, HR = 0.525, 95% CI = 0.271–1.021, p = 0.057). The gene discussed is PDCD1LG2; the disease is colorectal carcinoma.